Nature Communications (Aug 2024)

METTL3/METTL14 maintain human nucleoli integrity by mediating SUV39H1/H2 degradation

  • Yongli Shan,
  • Yanqi Zhang,
  • Yanxing Wei,
  • Cong Zhang,
  • Huaisong Lin,
  • Jiangping He,
  • Junwei Wang,
  • Wenjing Guo,
  • Heying Li,
  • Qianyu Chen,
  • Tiancheng Zhou,
  • Qi Xing,
  • Yancai Liu,
  • Jiekai Chen,
  • Guangjin Pan

DOI
https://doi.org/10.1038/s41467-024-51742-7
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Nucleoli are fundamentally essential sites for ribosome biogenesis in cells and formed by liquid-liquid phase separation (LLPS) for a multilayer condensate structure. How the nucleoli integrity is maintained remains poorly understood. Here, we reveal that METTL3/METTL14, the typical methyltransferase complex catalyzing N6-methyladnosine (m6A) on mRNAs maintain nucleoli integrity in human embryonic stem cells (hESCs). METTL3/METTL14 deficiency impairs nucleoli and leads to the complete loss of self-renewal in hESCs. We further show that SUV39H1/H2 protein, the methyltransferases catalyzing H3K9me3 were dramatically elevated in METTL3/METTL14 deficient cells, which causes an accumulation and infiltration of H3K9me3 across the whole nucleolus and impairs the LLPS. Mechanistically, METTL3/METTL14 complex serves as an essential adapter for CRL4 E3 ubiquitin ligase targeting SUV39H1/H2 for polyubiquitination and proteasomal degradation and therefore prevents H3K9me3 accumulation in nucleoli. Together, these findings uncover a previously unknown role of METTL3/METTL14 to maintain nucleoli integrity by facilitating SUV39H1/H2 degradation in human cells.